Eskayef Pharmaceuticals Ltd.
Private Limited | |
Industry | Pharmaceutical |
Founded | 1990 |
Headquarters | Gulshan, Dhaka, Bangladesh |
Website |
skfbd |
Eskayef Pharmaceuticals Limited, also known as SK+F, is a pharmaceutical company based in Bangladesh. It is part of the Transcom Group.[1][2] Simeen Hossain is the managing director & CEO of the company.[2][3]
History
Eskayef Bangladesh Limited (SK+F), a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990.[2] According to a 2008 survey by Intercontinental Marketing Services, the company placed among the top ten pharmaceutical companies operating in Bangladesh in terms of sales.[4] As of 2015, it exported its products to 21 countries across 4 continents, and had annual sales surpassing 128 million US dollars.[2] The company was renamed Eskayef Pharmaceuticals Limited in January 2017.[5]
The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products.[6]
References
- ↑ Iqbal, Farah K. (2016-09-19). "What makes the market tick?". Dhaka Tribune (Op-ed). Retrieved 2016-10-03.
- 1 2 3 4 "Eskayef sales jump manifold". The Daily Star. 2015-12-29. Retrieved 2016-10-03.
- ↑ "'I am the brand'". Prothom Alo. Retrieved 2016-10-03.
- ↑ Akter, Sayeda (2009-08-23). "Pharma industry set for expansion". The Daily Star. Retrieved 2016-10-03.
- ↑ "Eskayef pledges to conquer odds with courage". The Daily Star. 2017-01-24.
- ↑ "Eskayef beats rivals in sales growth". The Daily Star. 2012-01-26.
Further reading
- Rahman, Md Fazlur (2015-03-24). "Novo Nordisk: Ethically profitable". The Daily Star. Retrieved 2016-10-03.